Skip to content
FY'25FY'24FY'23FY'22
Profitability
Gross margin59.3%-0.4pp59.8%+2.2pp57.5%+12.4pp45.2%-9.2pp
Operating margin23%-3.9pp26.9%-2.6pp29.5%+22.3pp7.2%+0.8pp
Net margin8.1%-2.9pp11%+2.5pp8.5%+13.9pp-5.4%-31.2pp
Returns
Return on equity23.7%-8.9pp32.6%+7.9pp24.7%+37.2pp-12.6%-49.3pp
Return on invested capital125.6%121.9%+46.4pp
Efficiency
Asset turnover0.5×0.0×0.4×0.0×0.5×0.0×0.5×+0.1×
Liquidity
Current ratio1.6×+0.6×0.9×-0.2×1.2×+0.2×-0.2×
Leverage
Debt-to-equity0.0×0.0×0.0×0.0×
Net debt / EBITDA-1×-0.8×-0.3×+0.5×-0.7×+0.5×-1.3×+0.8×
Per Share
Book value per share$7.53+31.9%$5.71+20.5%$4.73-18.4%$5.80-2.4%
Valuation
Market capitalization$1.15B+20.4%$923.97M-7.9%$1B+28.9%$778.87M+20.6%
Price / earnings15.4×-6.4×13.4×-7.5×20.8×
Price / sales1.5×0.0×1.5×-0.3×1.8×+0.1×1.7×-0.7×
Price / book3.7×-0.4×-1.1×5.1×+1.1×+0.8×
EV / EBITDA3.5×+1.0×2.5×0.0×2.4×-2.3×4.7×-0.7×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Collegium Pharmaceutical, Inc.'s profit margins?
Collegium Pharmaceutical, Inc. (COLL) runs a 60.7% gross margin and a 23.7% operating margin, with a 9.4% net margin.
Where do Collegium Pharmaceutical, Inc.'s ratios come from?
Every ratio is computed from Collegium Pharmaceutical, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.